Komori
OncoTherapy Science (4564) · PolicyRestated

Speed of business execution, expansion of business areas, and balance between risk and return

First written in FY2016. 14 of 15 entries say "Restated". Latest entry: FY2026-H1.

15entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2026-H12016: 120162017: 120172018: 120182019: 220192020: 320202021: 220212022: 220222023: 120232024: 020242025: 22025
Same theme, other companies
Accelerating business execution, expanding the business portfolio, and balancing risk and returnsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026-H1RestatedAnnual report

    「In this business environment, the three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    Speed of business execution, expansion of business areas, and balance between risk and return continue to be the basic policy.
  2. FY2025RestatedAnnual report

    「In this business environment, the three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    The company reiterates speed of business execution, expansion of business areas, and balance between risk and return as its basic policy.
  3. FY2023-Q3RestatedAnnual report

    「In this business environment, the three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    The company reiterates speed of business execution, expansion of business areas, and balance between risk and return as its basic policy.
  4. FY2023-Q1RestatedAnnual report

    「In this business environment, the three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    The company reiterates speed of business execution, expansion of business areas, and balance between risk and return as its basic policy.
  5. FY2022-Q3RestatedAnnual report

    「In this business environment, the three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    The company reiterates speed of business execution, expansion of business areas, and balance between risk and return as its basic policy.
  6. FY2022-Q1RestatedAnnual report

    「In this business environment, the three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    The company reiterates speed of business execution, expansion of business areas, and balance between risk and return as its basic policy.
  7. FY2021-Q3RestatedAnnual report

    「In this business environment, the three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    The company reiterates speed of business execution, expansion of business areas, and balance between risk and return as its basic policy.
  8. FY2021-Q2RestatedAnnual report

    「In this business environment, the three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    The company reiterates speed of business execution, expansion of business areas, and balance between risk and return as its basic policy.
  9. FY2021-Q1RestatedAnnual report

    「In this business environment, the three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    The company reiterates speed of business execution, expansion of business areas, and balance between risk and return as its basic policy.
  10. FY2020-Q3RestatedAnnual report

    「In this business environment, the three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    The company reiterates speed of business execution, expansion of business areas, and balance between risk and return as its basic policy.
  11. FY2020-Q2RestatedAnnual report

    「In this business environment, the three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    The company reiterates speed of business execution, expansion of business areas, and balance between risk and return as its basic policy.
  12. FY2020-Q1RestatedAnnual report

    「The three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    Speed of business execution, expansion of business areas, and balance between risk and return continue to be the basic policy.
  13. FY2018RestatedAnnual report

    「The three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    Speed of business execution, expansion of business areas, and balance between risk and return continue to be the basic policy.
  14. FY2017RestatedAnnual report

    「The three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    Speed, expansion of business areas, and balance between risk and return continue to be cited as the basic elements of business development.
  15. FY2016First statedAnnual report

    「The three important elements in the Group's business development are the speed of business execution, expansion of business areas, and balance between risk and return.」

    The company describes responding to global competition in new drug development, expanding applications, and reducing risk through partnerships as an integrated management policy.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for OncoTherapy Science yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Speed of business execution, expansion of business areas, and balance between risk and return | OncoTherapy Science,Inc. (4564) | Komori